166 related articles for article (PubMed ID: 3405554)
1. The prognostic importance of steroid receptors in endometrial carcinoma.
Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
[TBL] [Abstract][Full Text] [Related]
3. Steroid hormone receptor content and lymph node status in endometrial cancer.
Morris PC; Anderson JR; Anderson B; Buller RE
Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
[TBL] [Abstract][Full Text] [Related]
4. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
[TBL] [Abstract][Full Text] [Related]
5. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
[TBL] [Abstract][Full Text] [Related]
6. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
[TBL] [Abstract][Full Text] [Related]
7. Influence of "nuclear" estrogen receptor content on prognosis of early stage carcinoma of the uterine body. A short-time follow-up.
Horvath G; Johnsson JE; Tropé C; Samuelsson L; Alm P; Olsson H
Neoplasma; 1990; 37(1):43-6. PubMed ID: 2320180
[TBL] [Abstract][Full Text] [Related]
8. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
Kleine W; Fuchs A; deGregorio G; Geyer H
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
[TBL] [Abstract][Full Text] [Related]
9. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
[TBL] [Abstract][Full Text] [Related]
10. [Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma--relation between clinical aspects and histopathology].
Gao YL
Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):451-4. PubMed ID: 3836850
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptor concentrations in endometrial carcinoma: effect on survival in surgically staged patients.
Kadar N; Malfetano JH; Homesley HD
Gynecol Oncol; 1993 Sep; 50(3):281-6. PubMed ID: 8406187
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
Hatae M; Yagi Y
Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
[TBL] [Abstract][Full Text] [Related]
13. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.
Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R
Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559
[TBL] [Abstract][Full Text] [Related]
14. [Endometrial cancer and steroid hormone receptors].
Nyholm HC
Ugeskr Laeger; 1990 Feb; 152(9):593-7. PubMed ID: 2408223
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progesterone receptors in uterine sarcomas.
Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
Demopoulos RI; Dubin N; Noumoff J; Blaustein A; Sommers GM
Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid receptors in endometrial cancer.
Chambers JT
Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
[TBL] [Abstract][Full Text] [Related]
19. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
Salvesen HB; Iversen OE; Akslen LA
Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
